Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability ...

Novartis (NVS) has announced that it will acquire Tourmaline Bio, Inc. (TRML), a New York-based, publicly traded clinical-stage biopharmaceutical company, for $1.4 billion. The acquisition will add ...

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their ...

What is the current share price of Tourmaline Bio (TRML)? Tourmaline Bio's (TRML) current share price is $47.64. This constitutes a price movement of 103.59% when compared to the share price 7 days ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Tourmaline Bio, Inc. (NASDAQ: TRML) to Novartis AG for $48.00 per share in cash is fair to Tourmaline shareholders.

Tourmaline Bio (TRML) has been catching investor attention recently, even without a specific event driving the headlines. Sometimes, stocks start to move or attract renewed interest for reasons that ...